Therapeutic potential of dietary phase 2 enzyme inducers in ameliorating diseases that have an underlying inflammatory component

被引:33
作者
Juurlink, BHJ [1 ]
机构
[1] Univ Saskatchewan, Coll Med, Dept Anat & Cell Biol, Saskatoon, SK S7N 5E5, Canada
[2] Univ Saskatchewan, Coll Med, Cameco Multiple Sclerosis & Neurosci Res Ctr, Saskatoon, SK S7N 5E5, Canada
关键词
Alzheimer's disease; atherosclerosis; diet; glutathione; inflammation; stroke;
D O I
10.1139/cjpp-79-3-266
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Many diseases associated with ageing have an underlying oxidative stress and accompanying inflammatory component, for example, Alzheimer's disease or atherosclerosis. Reviewed in this manuscript are: the role of oxidative stress in activating the transcription factor nuclear factor kappa B (NFkappaB), the role of NFkappaB in activating pro-inflammatory gene transcription, strong oxidants produced by cells, anti-oxidant defense systems, the central role of phase 2 enzymes in the anti-oxidant defense, dietary phase 2 enzyme inducers and evidence that dietary phase 2 enzymes decrease oxidative stress. It is likely that a diet containing phase 2 enzyme inducers may ameliorate or even prevent diseases that have a prominent inflammatory component to them. Research should be directed into the potential therapeutic effects of dietary phase 2 enzyme inducers in ameliorating diseases with an underlying oxidative stress and inflammatory component to them.
引用
收藏
页码:266 / 282
页数:17
相关论文
共 261 条
[31]   The nuclear factor kappa-B signaling pathway participates in dysregulation of vascular smooth muscle cells in vitro and in human atherosclerosis [J].
Bourcier, T ;
Sukhova, G ;
Libby, P .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1997, 272 (25) :15817-15824
[32]   Activated transcription factor nuclear factor-kappa B is present in the atherosclerotic lesion [J].
Brand, K ;
Page, S ;
Rogler, G ;
Bartsch, A ;
Brandl, R ;
Knuechel, R ;
Page, M ;
Kaltschmidt, C ;
Baeuerle, PA ;
Neumeier, D .
JOURNAL OF CLINICAL INVESTIGATION, 1996, 97 (07) :1715-1722
[33]  
BRAUGHLER JM, 1986, J BIOL CHEM, V261, P282
[34]   REACTIONS OF OXYL RADICALS WITH DNA [J].
BREEN, AP ;
MURPHY, JA .
FREE RADICAL BIOLOGY AND MEDICINE, 1995, 18 (06) :1033-1077
[35]   INVERSE ASSOCIATION OF ANTIINFLAMMATORY TREATMENTS AND ALZHEIMERS-DISEASE - INITIAL RESULTS OF A COTWIN CONTROL STUDY [J].
BREITNER, JCS ;
GAU, BA ;
WELSH, KA ;
PLASSMAN, BL ;
MCDONALD, WM ;
HELMS, MJ ;
ANTHONY, JC .
NEUROLOGY, 1994, 44 (02) :227-232
[36]  
Browne SE, 1999, BRAIN PATHOL, V9, P147
[37]   ADVANCED PROTEIN GLYCOSYLATION IN DIABETES AND AGING [J].
BROWNLEE, M .
ANNUAL REVIEW OF MEDICINE, 1995, 46 :223-234
[38]   THE PECKING ORDER OF FREE-RADICALS AND ANTIOXIDANTS - LIPID-PEROXIDATION, ALPHA-TOCOPHEROL, AND ASCORBATE [J].
BUETTNER, GR .
ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS, 1993, 300 (02) :535-543
[39]   A new kinetic model for the mode of action of soluble and membrane-immobilized glutathione peroxidase from bovine erythrocytes - Effects of selenium [J].
Carsol, MA ;
PouliquenSonaglia, I ;
Lesgards, G ;
MarchisMouren, G ;
Puigserver, A ;
Santimone, M .
EUROPEAN JOURNAL OF BIOCHEMISTRY, 1997, 247 (01) :248-255
[40]  
Chae HZ, 1999, METHOD ENZYMOL, V300, P219